Eisai announced that the FDA has approved Fycompa (perampanel tablets) as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy ...

Although its exact mechanism in the treatment of partial-onset seizures is unknown, cenobamate has been shown to reduce repetitive neuronal firing by inhibiting voltage-gated sodium currents. The Food ...

Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...

Dec. 12, 2002 — At the 56th annual meeting of the American Epilepsy Society, three reports of open-label testing of oxcarbazepine (Trileptal) suggest that the drug is safe and effective in adults and ...

Partial seizures are the most common seizure type in children. New antiepileptic drugs are needed because current treatments are often inadequate, or have intolerable adverse effects. Levetiracetam ...

The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating partial-onset seizures among children as young as 1 month. “When a child or infant ...

If your child has a seizure, it's natural to have plenty of concerns about what exactly happened, why, and what comes next. There are treatments that can help, but a lot depends on the cause of the ...

The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for perampanel (Fycompa; Eisai Inc) CIII as monotherapy to treat partial-onset seizures (POS) with or without ...